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Abstract
Nucleotide sequence analysis of multiple molecular clones of the hepatitis A virus (HAV), generated by reverse transcription-PCR of
two capsid-coding regions, revealed a degree of heterogeneity compatible with a quasispecies structure in three clinical samples. Passage
of plaque-purified reference strain HAV pHM175 43c in FRhK-4 cells documented the generation of a mutant distribution of HAV genomes.
The mutant spectra showed mutation frequencies in the range of 1  103 to 1  104 substitutions per nucleotide, with a dominance of
transition over transversion mutations. While in the VP3-coding region, nonsynonymous mutations were predominant; in the VP1-coding
region they were uncommon. Around 50% of the amino acid replacements involved residues located at or near antigenic sites. Most of the
detected mutations occurred at or in the vicinity of rare codons, suggesting a dynamics of mutation-selection, predominantly at and around
rare codons. The results indicate that despite antigenic conservation, HAV replicates as a complex distribution of mutants, a feature of viral
quasispecies.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
Hepatitis A virus (HAV), classified as the type species of
the genus Hepatovirus within the Picornaviridae family
(van Regenmortel et al., 2000), is a hepatotropic virus which
represents a significant problem for human health (Battegay
and Feinstone, 1997; Hollinger and Emerson, 2001). The
virion capsid is composed of the structural proteins VP1,
VP2, VP3, and possibly VP4, encoded in the P1 region of
the genome (Hollinger and Emerson, 2001; Racaniello,
2001).
Some degree of nucleotide sequence heterogeneity of the
P1 genomic region has been observed among independent
HAV isolates from different regions of the world (Lemon et
al., 1987; Robertson et al., 1992; Taylor, 1997; Arauz-Ruiz et
al., 2001; Costa-Mattioli et al., 2001). However, this variability
at the nucleotide level is not reflected in an equivalent degree
of variation at the amino acid level (Lemon and Robertson,
1993; Hollinger and Emerson, 2001; Sa´nchez et al., 2003). The
high degree of conservation of the amino acid sequences of the
capsid proteins of HAV entails a low antigenic diversity, and
therefore, only a single serotype of human HAV has been
recognized (Hollinger and Emerson, 2001). This suggests the
operation of severe structural constraints in the HAV capsid
(Sa´nchez et al., 2003). HAV shows a high codon usage bias,
with the repeated occurrence of 22 rare codons for 14 amino
acids (Sa´nchez et al., 2003). Most of the carboxy-terminal
regions of -barrels and -helices, that are predicted in the
capsid proteins (Luo et al., 1988), include residues encoded by
conserved rare codons, suggesting a potential function of such
codons in a decrease of the rate of translation to facilitate the
proper folding of the capsid proteins (Sa´nchez et al., 2003).
The molecular basis of the genetic variability of RNA
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viruses has been associated with the absence of a 3 3 5
exonuclease proofreading activity in viral RNA-dependent
RNA polymerases and reverse transcriptases, together with
lack of postreplicative repair mechanisms that can act on
DNA but not on RNA (Holland et al., 1992; Steinhauer et
al., 1992; Williams and Loeb, 1992; Domingo and Holland,
1997). Mutation rates for a variety of RNA viruses range
between 104 and 105 substitutions per nucleotide copied
(Batschelet et al., 1976; Drake, 1993; Drake and Holland,
1999). As a consequence, RNA viruses replicate as complex
dynamic mutant distributions, termed viral quasispecies (Ei-
gen and Biebricher, 1988; Holland et al., 1992; Domingo
and Holland, 1997; Domingo et al., 2001). The open reading
frame of the putative HAV 3D (the RNA-dependent RNA
polymerase) does not provide any evidence for the presence
of a proofreading or error-correcting activity known to be
associated with several DNA- dependent DNA polymerases
(Kunkel, 1988; Zimmern, 1988; Friedberg et al., 1995).
Therefore, mutation rates and frequencies for HAV are not
expected to differ significantly from those of other picorna-
viruses and RNA viruses in general (Drake and Holland,
1999). In this view, the 90% or higher amino acid sequence
identities among independent strains and isolates of HAV
(Hollinger and Emerson, 2001) would be the result of neg-
ative selection on many newly arising mutants and conver-
gence of consensus or average sequences (Eigen and
Biebricher, 1988; Holland et al., 1992; Domingo et al.,
2001). Yet if mutational pressure originated a number of
mutants hidden in a mutant spectrum, such mutants would
provide evidence of quasispecies dynamics, implying the
presence of a variant reservoir for HAV adaptation. Despite
the biological significance of this population structure, no
such analyses of HAV mutant spectra have been reported.
In the present work, results suggesting the occurrence of
distributions of related genomes in HAV are presented, both
with clinical isolates of HAV and in populations evolved in
cell culture from a biological clone of HAV. The nature of
the mutations detected in the mutant spectra supports the
operation of structural constraints in the capsid of HAV.
Furthermore, the results of HAV evolution in cell culture
revealed the presence of antigenic variants that were gen-
erated in the absence of immune selection-as-previously
observed with other viruses (Domingo et al., 1993).
Results
A mutant spectrum in clinical isolates of HAV
To test whether the limited amino acid variation among
consensus sequences of independent HAV isolates was par-
alleled by a homogeneous mutant spectrum within a HAV
population, a clonal analysis of three clinical samples of
HAV was performed. The samples were Val9 (stool), Val10
(stool), and Val12 (serum) (Sa´nchez et al., 2002), whose
origin is described under Materials and methods. A mean of
25 molecular clones from a single reverse transcription
(RT)-PCR amplification of a fragment of the VP3 (from
nucleotides 1470 to 1839, encoding amino acids 1 to 123)
and a fragment of the VP1 (from nucleotides 2459 to 2943,
encoding amino acids 85 to 245), which span sequences
encoding the main antigenic sites of HAV (Nainan et al.,
1992; Ping and Lemon, 1992; Bosch et al., 1998), were
analyzed for each sample. Minimum mutation frequencies
(counting repeated mutations only once) ranged between
1.2  103 and 1.4  104 substitutions per nucleotide
(Table 1). In some analyses, the maximum mutation fre-
quency (counting all mutations relative to the consensus)
increased over the minimal mutation frequency. The values
of Shannon entropy (a measure of the proportion of differ-
ent sequences in the set analyzed) indicated heterogeneity of
the mutant spectra. Control experiments (described in detail
under Materials and methods) indicated that the mutation
frequencies observed cannot be the result of misincorpora-
tions during RT-PCR amplification of HAV RNA. Statisti-
cal analysis (nonparametric Mann–Whitney U test and
ANOVA) revealed significant differences between the mu-
tation frequencies of the patient samples and the error rate
of the RT-PCR system, except in the Val10 sample. How-
ever, despite this lack of statistical significance, the local-
ization of the mutations (see below) make it extremely
unlikely that they could be just due to the occurrence of
random misincorporations. The mutation-frequencies and
Shannon entropies of the mutant spectra are in the range
observed in other viral quasiespecies (see Discussion).
A mutant spectrum in serially passaged HAV
pHM175 43c
The sequence comparisons indicated the occurrence in
the HAV isolates of dominant genomic sequences together
with several variants. These results suggest generation of
mutants in the course of replication of each individual HAV.
However, a definitive proof of mutant generation requires a
demonstration that multiple variants are produced de novo
upon replication of a single HAV genome (Domingo et al.,
1978; Domingo, 1996). To this effect, the reference HAV
strain pHM175 43c, adapted to FRhK-4 cells, was subjected
to three successive plaque isolations to produce pHM175
43c P0, and then this clonal population was subjected to 26
serial passages in the same cells (about 106 PFU infecting
106 cells per passage), as detailed under Materials and
methods. The resulting population is termed pHM175 43c
P26. No mutations were detected in the consensus se-
quences of the VP1- and VP3-coding regions analyzed, at
passages 1, 5, 11, 16, and 26. However, a clonal analysis
revealed 23 mutations in 100 molecular clones from passage
26 (Table 2). The minimum mutation frequencies were
7.0104 and 3.3104 substitutions per nucleotide for
the VP3- and VP1-coding regions, respectively. Only for
the VP3-coding region the maximum mutation frequency
was slightly higher than the minimum mutation frequency.
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Statistical analysis (nonparametric Mann–Whitney U test
and ANOVA) revealed significant differences between
these mutation frequencies and the experimental error rate.
The values of Shannon entropy indicated heterogeneity of
the mutant spectra. The consensus and the dominant se-
quences were identical. Thus, the results document con-
stancy of the average or consensus sequences, and the gen-
eration of a mutant spectrum upon replication of a
biological clone of HAV. These are features of quasispecies
dynamics (Eigen and Biebricher, 1988). Experiments are in
progress to elucidate whether the virus mutant distribution
varies with cell passage.
Types and location of mutations: mutation clustering
A dominance of transitions over transversions was ob-
served in all HAV mutant spectra analyzed (Tables 1 and 2).
In contrast, the ratio of synonymous-to-nonsynonymous
mutations was 33 for the VP1-coding region and 0.5 for the
VP3-coding region (average for all mutations detected in
the four mutant spectra analyzed, Tables 1 and 2). This
suggests higher constraints for variation at the amino acid
level for VP1 than for VP3. As expected, no bias was
observed in the few mutations recorded in the control am-
plification of an RNA transcript (basal RT-PCR error, de-
scribed under Materials and methods).
The positions of the mutations and amino acid substitu-
tions indicate the occurrence of several clusters of mutations
in the mutant spectra of both clinical samples and in the
clonal population pHM175 43c P26 (Fig. 1). Clusters of
substitutions at amino acid positions 37, 40, 41 and at 82,
83, 84 of VP3 in the mutant spectra of pHM175 43c P26,
and at 179, 180, and 181 of VP1 in the mutant spectra of the
clinical samples were remarkable. Some substitutions were
observed in independent mutant spectra (i.e., at positions
93, 104, 116, 131, 140, 181, and 217 of VP1), suggesting
Table 1
Characterization of the mutant spectrum of HAV in clinical samples
Genomic
region
Mutationsa
nucleotides
sequenced
Nucleotide mutation frequencyc Maximum amino
acid mutation
frequencyc
SNd
Tsb Tvb Nsynb Synb Indel or stopb Minimum Maximum
VP3 6/8773 3 3 4 2 0 6.8  104 6.8  104 1.3  103 0.31
Val9
VP3 1/6960 1 0 0 1 0 1.4  104 1.4  104 0 0.05
Val10
VP3 5/9913 4 1 4 1 0 4.0  104 5.0  104 1.2  103 0.22
Val12
VP1 40/13,035 38 2 0 40 0 1.2  103 3.1  103 0 0.50
Val9
VP1 2/9962 2 0 0 2 0 2.0  104 2.0  104 0 0.12
Val10
VP1 19/12,248 19 0 0 19 0 6.5  104 1.5  103 0 0.26
Val12
a Mutant residues are those that vary relative to the corresponding consensus sequences
b Detected mutations were classified into transitions (Ts) versus transversions (Tv) nonsynonymous (inducing an amino acid substitution) versus
synonymous or silent (not inducing an amino acid substitution) and insertion/deletion mutations (inducing an erroneous reading frame)
c The minimum nucleotide mutation frequency is the number of different mutations found divided by the total number of nucleotides sequenced. The
maximum nucleotide mutation frequency is the total number of mutations found divided by the total number of nucleotides sequenced. The maximum amino
acid mutation frequency is the total number of nonsynonymous mutations divided by the number of amino acids encoded in the sequence analyzed. Mutation
frequencies are expressed as substitutions per nucleotide or amino acid substitutions per amino acid.
d The normalized Shannon entropy was calculated as Sn  [i (pi  1npi)]/1nN, where pi is the frequency of each sequence and N is the total number of
sequences in the spectrum of mutants.
Table 2
Characterization of the mutant spectrum of the pHM175 43c P26
Genomic
region
Mutationsa
nucleotides
sequenced
Tsb Tvb Nsynb Synb Indel or stopb Nucleotide mutation frequencyc Maximum amino
acid mutation
frequencyc
SNd
Minimum Maximum
VP3 15/18,500 12 3 10 5 0 7.0  104 8.1  104 1.6  103 0.31
VP1 8/24,150 7 1 2 5 1 Stop 3.3  104 3.3  104 2.5  104 0.20
a Mutant residues are those that vary in comparison with the consensus sequence at P26.
b Detected mutations were classified as indicated in footnote b of Table 1.
c Mutation frequencies are as defined in footnote c of Table 1.
d The normalized Shannon entropy was calculated as indicated in footnote d of Table 1.
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Fig. 1. Amino acid sequence of the VP3 and VP1 fragments analyzed in the present study. (A) VP3 sequence of the pHM175 43c strain (B) VP3 sequence
of the clinical samples. (C) VP1 sequence of the pHM175 43c strain. (D) VP1 sequence of the clinical samples. In bold are depicted those amino acids
encoded by rare codons. Arrows indicate those positions in which a mutation occurred. Regarding the codon usage (Sa´nchez et al., 2003), the letter n
designates a normal (frequent) new codon;1n, a significantly more normal (frequent) new codon than the old one;2n, a significantly less normal (frequent)
new codon than the old one; and r, a rare new codon. Numbers in parentheses indicate the number of clones with a given substitution. At those positions
in which a nonsynonymous substitution occurred, the new amino acid is depicted over the sequence row. At position 72 in (B) either a valine or an isoleucine
may be present depending on the clinical sample.
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again the operation of constraints that limit the number of
positions that tolerate replacements, giving the appearance
of mutational hot spots (see Discussion). Seven of 15 amino
acid substitutions were either at residues previously identi-
fied as belonging to antigenic sites (i.e., 65, 72, and 115 of
VP3) or at residues in the neighborhood of antigenic sites
(i.e., 78, 83, 84, and 91 of VP3) (Ping and Lemon, 1992;
Bosch et al., 1998; Hollinger and Emerson, 2001).
A large proportion of mutations in the mutant spectra
analyzed involved either rare codons, defined as those
codons used at low frequencies (Gavrilin et al., 2000) or
normal codons located in the neighborhood of rare codons
(at a maximum distance of three triplets from a rare codon)
(Fig. 1). The majority of the mutations involving rare
codons (90%) resulted in the change to a normal codon.
However, most of the resulting normal codons (78%) were
contiguous to a rare codon (Fig. 1). In contrast, most mu-
tations involving normal codons (74%) induced changes
which significantly affected the normality of the codon, and
a high percentage of them (72%) were again closely located
to rare codons (Fig. 1). Therefore, both the types of muta-
tions and the types of codons affected suggest variation
constraints in HAV.
Discussion
Despite the invariance of consensus sequences, at the
VP3- and VP1-coding regions examined, upon serial pas-
sage of a biological clone of HAV, each of the populations
analyzed consisted of a mutant spectrum in agreement with
a quasispecies population structure for this important human
pathogen (Tables 1 and 2). From the minimum mutation
frequencies and since the HAV genome is about 7500 nu-
cleotides in size [specifically, the genome of the original
HM175 wild-type HAV is 7493 nucleotides long (Cohen et
al., 1987) and the genome of the cell culture-adapted strain
pHM175 43c is 7503 nucleotides long (Lemon et al.,
1991)], the average number of mutations per genome (rel-
ative to the consensus sequence) for Val9, Val10, Val12,
and the clonal population pHM175 43c P26 is 7.0, 1.2, 3.9,
and 3.8, respectively. This calculation assumes that the
mutation frequencies for the analyzed genomic regions re-
flect those of other genomic regions, a point that would
require sequencing of other genomic regions from compo-
nents of mutant spectra. However, comparison of nucleotide
sequences from different HAV isolates suggests a consid-
erable similarity in the degree of conservation of different
genomic regions (Hollinger and Emerson, 2001; Ching et
al., 2002; Sa´nchez et al., 2003). In these comparisons, the
most variable genomic regions are those encoding 2B, 2C,
and 3B (representing 25% of the genome), with an average
of 1.1-fold the genetic distance calculated for the analyzed
VP3- and VP1-coding regions, the most conserved genomic
regions are the highly conserved noncoding regions and
those encoding 3C and 3D (representing 39% of the ge-
nome), with an average of 0.8-fold the genetic distance
calculated for the VP3- and VP1-coding regions. Since in
other viruses conservation among independent isolates often
parallels conservation within mutant spectra (Arias et al.,
2001; Domingo et al., 2001), the heterogeneity quantitated
on the basis of the VP3- and VP1-coding regions analyzed
is unlikely to differ substantially from the heterogeneity for
the entire HAV genome. With this assumption, the propor-
tion of genomes with no mutations (the dominant se-
quence), calculated from the Poisson, distribution, would be
0.09, 30, 2.0, and 2.2% for Val9, Val10, Val12, and pHM
175 43c P26 respectively. These values are comparable to
those estimated for clonal populations of other RNA viruses
such as bacteriophage Q (Domingo et al., 1978) or FMDV
(Sobrino et al., 1983; Arias et al., 2001; review in Domingo
et al., 2001). Thus, in these HAV populations the nonmu-
tated class of genomes were a minority of the total.
Of the analyzed mutant spectra, only Val10 had a level of
heterogeneity that could be influenced by misincorporations
during RT-PCR amplification. Several arguments support
the fact that the great majority of the mutations found, even
in Val10, was present in the RNA populations under study
and were not the result of misincorporations during the
RT-PCR procedure employed. First, a basal error rate for
the RT-PCR procedures was experimentally determined for
the same VP3- and VP1-coding regions under study. This
control experiment (detailed under Materials and methods)
used recombinant clones to prepare VP3 and VP1 tran-
scripts with T7 DNA-dependent RNA polymerase. The
transcripts were then subjected to the same RT-PCR ampli-
fication used with HAV RNA and 50 cDNA clones were
sequenced. The final error rate attributable to the system is
7.9  105 by 8.1  105 substitutions per nucleotide for
the VP3- and VP1-coding regions, respectively. Moreover,
the mutations that occurred during the RNA synthesis and
the RT-PCR amplification (three transitions and two trans-
versions, three nonsynonymous and two synonymous mu-
tations) did not show any of the mutational type bias or
mutation clustering observed in the HAV populations. For
obvious statistical reasons, the probability of mutation clus-
tering as an RT-PCR artifact is negligible. The mutations in
the mutant spectrum of Val10 were located in the vicinity of
the sites where mutations for the other samples have been
mapped. Therefore, the vast majority of mutations scored in
the mutant spectra must have been present in the HAV RNA
populations examined. Although it cannot be excluded that
some mutation could have been generated during the in
vitro amplification procedure, its exclusion would not sig-
nificantly modify the quantifications and conclusions on
mutant spectrum complexity of HAV. The narrower mutant
spectrum in Val10 could not be the result of a limitation in
the number of RNA template molecules in the sample, since
in all cases a dilution of at least 1:100 of the preparation of
the RNAs used as template produced a positive amplifica-
tion, which excludes a bias in the sequence repertoire
(Airaksinen et al., 2003). The narrower mutant spectrum of
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this isolate could result from a shorter time from a clonal
origin of the infection, a limited HAV replication, or higher
sequence constraints than for the other isolates, among other
possibilities (Domingo et al., 2001).
A complex mutant spectrum for HAV isolates poses a
problem regarding the concept of strain for this virus. For
hepatitis C virus, a genomic distance higher than 5%, in a
genomic fragment encompassing the E2-NS2 junction, is
required for two HCVs to be considered a different strain
(Cabot et al., 2000), and different HAV and poliovirus
genotypes are those with higher than 15% nucleotide se-
quence divergence in the VP1-2A-coding region (Rico-
Hesse et al., 1987; Hollinger and Emerson, 2001). As more
consensus sequences and data on mutant spectra of HAV
become available, it may be necessary to redefine limits for
strain and genotype classifications.
The mean ratio of transition to transversion mutations in
the RNA of the analyzed populations was 8.6, probably
reflecting the misincorporations tendencies of RNA depen-
dent RNA polymerases (Domingo et al., 1978; Kuge et al.,
1989; Schnerder and Roossinck, 2000). Also, the proportion
of transitions tends to decrease with the divergence of the
genes compared (Villanueva et al., 1983; Nei, 1987), sup-
porting a recent occurrence of the mutations observed in
these HAV samples. Examination of the sequence context in
which mutations are found indicates that 25% of the muta-
tions in clusters are located at the ends of short oligo (A) or
oligo (U) stretches, suggesting a possible contribution of
polymerase slippage in the generation of some of these
mutations (Ripley, 1990; Arias et al., 2001). However not
all homopolymeric tracts were associated with mutations
only 2 of 14 (2/14) A3 tracts; 3/33 U3; 1/7 A4; 1/10 U4; 2/3
A5; 4/8 U5.
Several amino acid substitutions in components of the
mutant spectra are located at or near recognized antigenic
sites of HAV (Fig. 1). In particular in population pHM175
43c P26 passaged in cell culture in the absence of immune
selection, substitutions at positions 65 (Pro 3 Leu), 83
(Pro3 Ser), and 84 (Tyr3 Asn) of VP3 are related to the
immunodominant site of HAV (Nainan et al., 1992; Luo et
al., 1988), and 115 (Leu3 Phe) and 91 (Thr3 Lys) affect
a continuous epitope of VP3 (Bosch et al., 1998; M. Luo,
personal communication). Antigenic variation in the ab-
sence of immune selection has been observed in several
other viruses (reviewed in Domingo et al., 1993) and has
been attributed to higher tolerance to replacements of sur-
face residues which are relatively free of structural con-
straints (Domingo et al., 1993; Haydon and Woolhouse,
1998). Replacements at or in the neighborhood of antigenic
sites were also found in the mutant spectra of Va19 [sub-
stitution Va13 Ile at position 72 of VP3, which is involved
in the epitope defined by the monoclonal antibody K34C8
(Sa´nchez et al., 2002)] or of Val12 [substitutions Ile3 Val
at position 72 of VP3, and Val3Leu at position 78 of VP3].
These replacements are in the vicinity of the immunodom-
inant site (Luo et al., 1988).
One of the unusual features of HAV is the abundance of
rare codons at some capsid sites, compatible with a modu-
lating effect on HAV translation (Sa´nchez et al., 2003). The
fact that the mutations observed tended to maintain a min-
imal frequency of rare codons suggests a constraint in the
dynamics of mutation-selection to preserve the previously
postulated balance between rate of translation and capsid
protein folding (Sa´nchez et al., 2003). In HAV, this may be
an important evolutionary constraint, additional to those
generally accepted to limit evolutionary rates of RNA vi-
ruses despite high mutation rates (Simmonds and Smith,
1999).
A quasispecies dynamics for HAV may be of conse-
quence for the natural history of this pathogen and its
control in the human population. Pathogenic manifestations
of HAV are quite variable (reviewed in Hollinger and Em-
erson, 2001). Patients may be asymptomatic despite active
viral replication, but relapsing and fulminant forms of hep-
atitis, as well as extrahepatic manifestations such as enceph-
alopathy, have been described. Although a strong host com-
ponent undoubtedly must influence disease outcome, a
possible participation of virus variants to respond to host
defense mechanisms or to favor replication in the face of
physiological alterations cannot be excluded. In this con-
text, it is remarkable that the pattern of mutations found in
the analyzed VP3 and VP1 regions differed between the
pHM175 and the clinical isolates, likely due to different
selective pressures. The existence of variant reservoirs in
HAV populations should also be taken into consideration in
the design of preventive and therapeutic treatments, despite
antigenic conservation of the virus.
Material and methods
Cells, viruses, and infections
The cytopathogenic pHM175 43c strain of HAV (cour-
tesy of T. Cromeans, Centers for Disease Control, Atlanta,
GA) was three times plaque-purified in FRhK-4 cells, as
previously described (Cromeans et al., 1987), and a biolog-
ical clone (pHM175 43c P0) was serially passaged 26 times
in the same cell line, as previously described (Bosch et al.,
1998) to yield population pHM175 43c P26.
Clinical samples
Three HAV strains were isolated from three different
patients of an outbreak of acute hepatitis A associated with
the consumption of coquina clams in Valencia, Spain, dur-
ing autumn–winter 1999 (Sa´nchez et al., 2002). One virus
strain (Va19) was isolated from 60 l of serum, and two
additional strains (Va110 and Va112) were isolated from 60
l of extracted feces as previously described (Sa´nchez et al.,
2002). All strains belonged to genotype IB and presented an
overall nucleotide homology of the consensus sequences of
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99.7% in a fragment of the 5NCR and 99.3% in the region
encoding the VP1-2A junction (Sa´nchez et al., 2002), which
indicates an epidemic relationship among them.
Molecular cloning and sequencing
RNA extracted from pHM175 43c P26 or from the clin-
ical samples was retrotranscribed to a cDNA with the M-
MLV reverse transcriptase (Promega), and the cDNA was
copied and amplified by the thermostable Pwo pol from
Pyrococcus woesei, which has proofreading activity (error
rate of 3.2106 substitutions/nucleotide) (Mullan et al.,
2001). Two genomic regions coding for capsid proteins
were amplified. A fragment of the VP3-coding region (nu-
cleotides 1470 to 1839, corresponding to amino acids 1 to
123) and a fragment of the VP1-coding region (nucleotides
2459 to 2943, corresponding to amino acids 85 to 245),
which include most of the epitopes so far described in HAV
(Nainan et al., 1992; Ping and Lemon, 1992; Bosch et al.,
1998). The primers used to copy and amplify the VP3-
coding region are NH2-VP3 (5 TCTACCTGAAT-
GATATTTGG 3) for the cDNA synthesis, and NH2-VP3
and VP3-1431B (5 CTTGGATCCCACTCAATGTTT-
TAGCTAGA 3) for, PCR amplification. The primers used
to copy and amplify the VP1-coding regions are VP1-2965
(5 TCTGTGACAGACAGACAAATAACAAC 3) for the
cDNA synthesis, and VP1–2965 and VP1-2428 (5 GAGG-
GATCCGACATACATCAGATCATATGTC 3) for PCR
amplification. The synthesis of cDNAs was performed in a
final volume of 25 l containing 8 units of M-MLV RT, 0.2
mM of each nucleotide, 0.5 M primer, 50 mM Tris–HC1,
75 mM KCl, 3 mM MgCl2, and 10 mM DTT. Ten microli-
tus of HAV RNA was denatured at 99°C for 5-min and
incubated at 45°C for 1 h. DNA amplification was per-
formed following the manufacturer’s specifications in a
final volume of 50 l containing 0.5 U of the Pwo pol, 0.2
mM of each nucleotide 0.5 M of each primer, 10 mM
Tris–HCl, 25 mM KC1, 5 mM (NH4)2SO4, 2 mM MgSO4,
and 10 l of the RT product, and using an annealing tem-
perature of 50°C in both reactions. Since the DNA frag-
ments produced by Pwo pol are blunt-ended, and primers
VP3–1431B and VP1–2428 were designed to include a
BamHI restriction site at their 5 end, the amplification
products were cloned into pGEM-3Zf(). PCR products
were digested with BamHI and the plasmid vector with both
BamHI and HincII. Digested DNAs were purified with the
High Pure PCR Product Purification Kit (Roche) following
the directions of the manufacturer. DNA ligations were
performed overnight at 16°C using T4 DNA ligase. Ligation
products were transformed in Escherichia coli DH5, and
transformant clones were screened first by the standard
white/blue -galactosidase colorimetric reaction and then
confirmed by colony hybridization with specific digoxige-
nin-labeled probes. Plasmid DNA from each clone was
purified by using the Wizard Plus SV Minipreps Kit (Pro-
mega). Nucleotide sequencing was carried out in an ABI
PRISM 377 automated DNA sequencer, with the ABI
PRISM BigDye Terminator Cycle Sequencing Ready Re-
action Kit (Applied Biosystems) and using vector-derived
primers, as described elsewhere (Arias et al., 2001). All
mutations were confirmed by sequencing both strands of
DNA.
Error rate of the RT-PCR system
To ensure that the observed heterogeneity was due to the
HAV polymerase and not to artifactual misincorporations
introduced by the RT or Pwo polymerases during the am-
plification procedure, a control experiment to determine the
error rate of the system was carried out. One recombinant
clone of the VP3 fragment and one recombinant clone of the
VP1 fragment, obtained by copying RNA from pHM175
43c, were in vitro transcribed with the T7 polymerase. The
RNA transcripts, diluted 1/1000, were subjected to the orig-
inal RT-PCR procedure and the amplified products were
subcloned. The sequence of 50 clones from each VP3- and
VP1-coding region yielded an error rate for the amplifica-
tion system of 1.1  104 and 1.7  104 mutations per
nucleotide, respectively. Since the error rate of the T7 RNA
polymerase is about 2.9 105 (Remington et al., 1998),
the final error rate of the system was calculated to be
8.1105 and 1.4104 for the VP3- and VP1-coding
regions, respectively. The ANOVA and the nonparametric
Mann–Whitney U tests were employed to compare viral
mutation frequencies and the system error rates, revealing
statistical significance in all but one case (Va110). These
data, together with the types and location of the mutations
scored (described under Results and Discussion) indicate
that the vast majority of mutations detected must have been
present in the mutant spectra of the HAV samples analyzed.
Sequence analysis
The quasispecies complexity was analyzed by calculat-
ing the mutation frequencies and the Shannon entropy.
Minimum and maximum mutation frequencies were deter-
mined as previously described (Arias et al., 2001). Normal-
ized Shannon entropies were calculated following the for-
mula Sn  [i (pi  lnpi)]/lnN, where pi is the frequency
of each sequence and N is the total number of sequences in
the spectrum of mutants (Airaksinen et al., 2003). Sn ranges
from 0 (no diversity) to 1 (maximum diversity). The codon
usage table of HAV defined previously (Sa´nchez et al.,
2003) was used in the analyses of codon abundances.
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